Employer Health Benefit Costs Rise 7.3% to $18,777 per Employee in 2026, Marsh Survey Finds

By Public Technologies
  • Marsh's survey found employer-sponsored health benefit costs rose 7.3% to $18,777 per employee in 2026.
  • Employers project an 8.2% increase in 2027, pushing average costs above $20,000 per employee.
  • Prescription drug spending rose 9.7% among large employers, contributing to rising benefit costs.
  • Large employers covering GLP-1 weight-loss medications fell to 41% in 2026 from 49% in 2025 as employers sought cost controls.
  • To address affordability, 31% of large employers now offer plans steering employees toward smaller networks of higher-performing providers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MMC - Marsh & McLennan Companies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261117717353) on November 17, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.